v1.4.2 - enhancements

demo/data.json

@@ -31,6 +31,7 @@
               "id": 1101,
               "name": "试验方案设计与<span style='font-weight: bold;color:red;'>伦理审查</span>",
               "assignee": "方案设计师 李明",
+              "avatar": "https://i.pravatar.cc/150?img=1",
               "startDate": "2025-01-01",
               "endDate": "2025-02-28",
               "progress": 100,
@@ -45,6 +46,7 @@
               "id": 1102,
               "name": "受试者招募与筛选",
               "assignee": "招募专员 张丽",
+              "avatar": "https://i.pravatar.cc/150?img=5",
               "startDate": "2025-03-01",
               "endDate": "2025-04-30",
               "progress": 90,
@@ -60,6 +62,7 @@
               "id": 1103,
               "name": "药物给药与安全性监测",
               "assignee": "临床医生 Dr. Liu",
+              "avatar": "https://i.pravatar.cc/150?img=8",
               "startDate": "2025-05-01",
               "endDate": "2025-08-31",
               "progress": 40,
@@ -92,6 +95,7 @@
               "id": 1201,
               "name": "多中心试验<span style='font-weight: bold; color: blue;'>启动</span>",
               "assignee": "项目经理 王芳",
+              "avatar": "https://i.pravatar.cc/150?img=10",
               "startDate": "2025-09-01",
               "endDate": "2025-11-30",
               "progress": 25,
@@ -107,6 +111,7 @@
               "id": 1202,
               "name": "患者入组与随机化",
               "assignee": "数据管理员 陈静",
+              "avatar": "https://i.pravatar.cc/150?img=20",
               "startDate": "2025-12-01",
               "endDate": "2026-03-31",
               "progress": 0,
@@ -122,6 +127,7 @@
               "id": 1203,
               "name": "疗效评估与数据收集",
               "assignee": "统计师 赵磊",
+              "avatar": "https://i.pravatar.cc/150?img=15",
               "startDate": "2026-01-01",
               "endDate": "2026-08-31",
               "progress": 0,
@@ -421,7 +427,7 @@
       "startDate": "2025-08-31",
       "endDate": "2025-08-31",
       "type": "milestone",
-      "icon": "shield-check",
+      "icon": "diamond",
       "description": "完成I期临床试验，确认ADX-2024在人体的安全性和耐受性，为II期试验奠定基础。"
     },
     {
@@ -431,7 +437,7 @@
       "startDate": "2026-04-30",
       "endDate": "2026-04-30",
       "type": "milestone",
-      "icon": "bar-chart",
+      "icon": "diamond",
       "description": "完成II期临床试验中期疗效分析，评估是否继续进行III期试验。"
     },
     {
@@ -441,7 +447,7 @@
       "startDate": "2027-12-31",
       "endDate": "2027-12-31",
       "type": "milestone",
-      "icon": "trophy",
+      "icon": "diamond",
       "description": "完成III期临床试验最终分析，向监管部门提交新药上市申请(NDA)。"
     },
     {